Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-09-15

Clinical Trial Update: Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating urinary aquaporin-2 in patients with syndrome of inappropriate antidiuretic hormone secretion caused by antiepileptic the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Regional Hospital Holstebro | Conditions: Syndrome of Inappropriate ADH-secretion | Phase 4 | Status: WITHDRAWN